AVXL Jan 2024 5.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:10AM EST. Market open.
Loading interactive chart…
- Simply Wall St.
We Think Anavex Life Sciences (NASDAQ:AVXL) Can Easily Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although...
- Zacks
FDA Rejects Accelerated Nod to Lilly's (LLY) Alzheimer's Drug
The FDA rejects Eli Lilly's (LLY) seeking accelerated approval of a new Alzheimer's drug, donanemab, due to the limited number of patients with at least 12 months of drug exposure data.
- Motley Fool
3 Biotech Stocks Under $15 Worth a Second Look in 2023
Novavax stands out with its more traditional, protein-based COVID-19 vaccine; MannKind is making a name for itself with inhaled therapies for diabetics and patients with lung disorders; and Anavex has a promising Alzheimer's therapy.
© 2023 Yahoo. All rights reserved.
